Looking for stocks to buy; here are five stocks to watch - Oct 4th-7th 2022
Summary: Five stocks to watch this week, in our two minute video. CSL could likely see a pickup in flu-vaccine demand and revenue ahead of the Northern Hemisphere winter. Rio Tinto, is another to watch as it just started producing spodumene concentrate for lithium batteries. Tesco and Constellation Brands are also on watch with results out this week. And Insurance Australia Group is also on watch with the RBA making a bevy of more interest rates hikes. Will IAG continue to outperform?
CSL is the one of the world’s biggest producers of influenzas vaccines. The thinking is CSL’s revenue could pick up with flu vaccine demand likely to rise ahead of the Northern Hemisphere winter.
Rio Tinto (RIO)
Rio just started producing spodumene concentrate for lithium batteries, at its facility in Canada. Rio is also one of the world’s largest producers of Iron Ore (SCOA) and Aluminium. And last week, Aluminium prices saw their biggest jump on record on potential supply fears. So its worth watching to see what eventuates.
Tesco, The British Super market giant is due to release financial results in the first week of October, while also kicking off a huge half price toy sale in a bid to boost its performance. Tesco shares are trading at 4 year lows.
Constellation Brands (STZ)
Constellation Brands is the business that makes and producers beers such as Corona. It also produces and sells Wines and Sprits. the Alcohol giant is due to report results in the first week of October. And it’s worth watching their shares as they’ve outperformed the market this year.
Insurance Australia Group (IAG)
IAG is Australia’s largest insurance group. Insurance groups generally do well when interest rates rise. So with the Reserve Bank of Australia (RBA) expected to rise rates in the first week of October and for the rest of the year and into next year, IAG is worth watching. IAG shares have outperformed the market and risen 6% this year.
To find out more about the these companies or other opportunities, head to Saxo's Platform.
Q4 Outlook 2022: Winter is coming
- Winter is coming to the financial markets as central banks are tightening their grip. How spring will look is still a question.
European energy crisis: it will get worse before it gets betterThe winter in Europe will be tough, but whether the result is political chaos or sustainable, innovative solutions is still undecided.
A difficult and volatile quarter awaitsAs the year draws to an end, commodities continue to be at centre stage of the world with growth pockets political uncertainty.
The bright side: crises drive innovationThe positive spin on crises is that they come with solutions. It is worrisome that deglobalisation may be a response to this crisis.
Green transformation in China: renewable energy and beyondGoing green, China needs to span numerous energy sources to ensure stability, as every source comes with a challenge.
Asia: Intermittent solutions, but a faster renewable adoption curveAsian energy supply is being squeezed. This and the adoption of renewables may change the investment sentiment in the region.
FX: A Fed thaw needed to deliver a sustained USD turn lowerThe US Dollar can keep momentum when the Federal Reserve continues to tighten, leaving the rest to play to their drum.
Autumn can become ugly for equities and bond holders. Comfort for Dollar longsTechnical analysis suggests that equities could face a tough Q4 as could fixed income. US Dollar positions could provide some upside.
The next stock market sector to watch, with stocks going nuclearAs the world scrambles to find affordable, sustainable energy, nuclear is getting attention from politicians and investors alike.
The crypto space is getting cold when the hype disappearsCryptocurrencies face a winter of their own as retail investors and governments are asking tough questions.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)